Article Details
Retrieved on: 2025-01-29 19:16:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CAMBRIDGE, Massachusetts, Jan. 29, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company ...
Article found on: financialpost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here